Upload
mayapuspitasariunsri
View
221
Download
5
Embed Size (px)
Citation preview
MORNING REPORT
Monday, December 1th, 2014 at 02.00 PM Tuesday, December 2nd, 2014 at 07.00 AMPhysiologic obstetrical patient
: 2 casesPathologic obstetrical patient
: 5 casesGynecological patient
: 0 casePassed Away
: 0 case
Total patient
: 7 casesObstetric ward patients
: 21 patients
Gynecology and Oncology ward patients: 33 patients
ICU patient
: 1 patientTotal Patients
: 55 patients
OBSTETRICS
1.01.12.14Conservative management Mrs.IND/23/UA/LAT
05.30 PMD/ G2P1A0 34 weeks gestational age not inlabor with PROM 16 hours SLF cephalic presentation + moderate anemia
Hb: 7.6 g/dlWBC : 13.500/mm3Plt : 198.000/L
CRP (-)US ER (IDA) :
SLF cephalic presentation
Fetal biometry :
BPD 8,49 cm FL 6,21 cm
HC 29,8 cm EFW 2160 gAC 29,2 cm
Amniotic fluid AFI 1,08 0,80 = 6,06 cm
2,12 2,06 Placenta at anterior of uterine corpus
C/ 34 weeks gestational age SLF cephalic presentation
M/ Conservative management
Nifedipine 10 mg tab / 6 hours Ampicillin 1 g iv (ST)/6 hours Dexamethason inj 12 mg / 24 hours (2 days) PRC transfusion
P/ US confirmation
2.01.12.14Conservative management Mrs. FEN/28/RA/LAT
08.20 PMD/ G1P0A0 33 weeks gestational age not inlabor with PROM 9 hours SLF cephalic presentation
Hb: 11.4 g/dl
WBC : 21.700/mm3Plt : 343.000/L
CRP (-)US ER (IDA) :
SLF cephalic presentation
Fetal biometry :
BPD 8,4 cm FL 6,17 cm
HC 28,9 cm EFW 1840 gAC 27,5 cm
Amniotic fluid AFI 1,12 1,03 = 5,17 cm
1,35 1,67 Placenta at posterior of uterine corpus
C/ 33 weeks gestational age SLF cephalic presentation
M/ Conservative management
Nifedipine 10 mg tab / 6 hours Ampicillin 1 g iv (ST)/6 hours Dexamethason inj 12 mg / 24 hours (2 days)
P/ US confirmation
3.02.12.14LSCS due to fetal distress Mrs. ELA/18/RA/SUG
03.30 AMFHR I : 188 x/m
FHR II: 182 x/m
FHR III : 179 x/mD/ G1P0A0 38 weeks gestational age inlabor 1st stage active phase with history of ROM 1 day SLF breech presentation + fetal distress
M/ Intrauterine rescucitation: lateroposition, O2 5l/m Laboratory examination Ceftriaxone inj. 2 x 1 g iv (ST)
P/ Abdominal delivery
Consult to consultant on duty ( agree for abdominal delivery
04.20 AMFemale live baby was born, BW 3000g, BL 47cm, AS 7/9 FT AGA
04.23 AMPlacenta was delivered completely, PW 520 g, umbilical cord length 48cm, 19x20cm
02.12.1406:00 AMMother and baby were in good condition
4.29.11.14Plan for LSCS due to impending eclampsia
Mrs.IPA/34/RA/SUG
01.00 PM GI : 6D/ G3P2A0 31 weeks gestational age not inlabor with severe preeclampsia SLF breech presentation
Hb : 9.3 g/dl
Plt : 221.000/LSGOT : 21U/LSGPT : 13 U/LLDH : 358 U/LM/Expectative management MgSO4 inj. protocol
Nifedipine 10 mg / 8 hours Evaluation with gestosis task Consult to Internal Departement, Ophthalmology
01.12.1412.45 PM
US (PM):
SLF breech presentation
Fetal biometry :
BPD 7,74 cm FL 5,79 cm
HC 27,82 cm EFW 1245 g
AC 22,47 cm
Amniotic fluid was enough
Placenta at anterior of uterine corpus BPP : FM 2, FB 2, FT 2, ICA 2, NST 0 ( 8
C/ 32 weeks gestational age SLF breech presentation + BPP 8 +IUGR was suspected
Consult to supervisor fetomaternalAdvice : Lung maturation 2 days
Terminate the pregnancy
P/ Elective cesarean section (Tuesday, 2 December 2014)
02.12.1401.00 AMG3P2A0 31 weeks gestational age not inlabor with impending eclampsia SLF cephalic presentation
GI : 4M/ Terminate the pregnancy (abdominal delivery)
Consult to consultant on duty :
( agree for abdominal delivery
5.02.12.14LSCS due to fetal distress Mrs. IIN/24/UA/SUG
04.30 AMFHR I : 188 x/m
FHR II: 182 x/m
FHR III : 170 x/mD/ G1P0A0 42 weeks gestational age inlabor 1st stage latent phase with PROM 2 days SLF cephalic presentation + fetal distress
M/ Intrauterine rescucitation: lateroposition, O2 5l/m Laboratory examination Ceftriaxone inj. 2 x 1 g iv (ST)
P/ Abdominal delivery
Consult to consultant on duty ( agree for abdominal delivery
Cesarean section was on going